Antagonist Treatment for Opioid Use Disorder
Am J Med
.
2017 Mar;130(3):e117.
doi: 10.1016/j.amjmed.2016.08.048.
Authors
Bernard L Silverman
1
,
Sarah C Akerman
1
Affiliation
1
Alkermes, Inc, Waltham, Mass.
PMID:
28215953
DOI:
10.1016/j.amjmed.2016.08.048
No abstract available
Publication types
Letter
Comment
MeSH terms
Humans
Naltrexone*
Narcotic Antagonists*
Opioid-Related Disorders
Substances
Narcotic Antagonists
Naltrexone